Advertisement
Advertisement
U.S. markets open in 8 hours 34 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Sana Biotechnology, Inc. (SANA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.41+0.23 (+2.81%)
At close: 04:00PM EDT
8.65 +0.24 (+2.85%)
After hours: 06:36PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Inside Bar (Bearish)

Inside Bar (Bearish)

Previous Close8.18
Open8.28
Bid0.00 x 4000
Ask0.00 x 800
Day's Range8.22 - 8.66
52 Week Range3.92 - 26.60
Volume1,330,841
Avg. Volume1,542,240
Market Cap1.6B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.13
Earnings DateNov 07, 2022 - Nov 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.33
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SANA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Sana Biotechnology, Inc.
    Daily – Vickers Top Buyers & Sellers for 03/23/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    5 months agoArgus Research
View more
  • InvestorPlace

    7 Stocks Due for a Stunning Short Squeeze

    Although the general rule of thumb is to avoid equities with heavy short interest, the new normal has brought with it new paradigms. One of these fresh approaches urges speculators to acquire short-squeeze stocks in an effort to move the equities higher, forcing the bears to cover their short positions. Of course, short covering raises the prices of the affected securities, ultimately creating a bullish bonanza. Throughout this list of short-squeeze stocks, I will refer to two concepts. The firs

  • GlobeNewswire

    Sana Biotechnology Reports Second Quarter 2022 Financial Results and Business Updates

    Expect cash runway into 2025, enabling multiple data readouts across platforms for lead programs, driven by significant cash savings from manufacturing facility move to Bothell, Washington as well as research prioritization Expect to file INDs this year for SC291 and SG295 Presented preclinical data showing survival of transplanted hypoimmune allogeneic pancreatic islet cells, cardiomyocytes, and retinal pigment epithelium cells without immunosuppression in non-human primates Q2 2022 cash positi

  • GlobeNewswire

    Sana Biotechnology Presents Data at ISSCR 2022 Annual Meeting Showing Survival of Transplanted Hypoimmune iPSC-Derived Differentiated Cell Types Without Immunosuppression in Non-Human Primates

    First demonstration of the survival of allogeneic islet cells, cardiomyocytes, and retinal pigment epithelium cells transplanted into an immunocompetent non-human primate model without any immune suppression The islet autoimmune data suggest that cells with hypoimmune (HIP) edits evade allogeneic immune response and autoimmune response in a type 1 diabetes mouse model Transplanting allogeneic cells into a non-human primate without immune suppression represents a key step toward development of en

Advertisement
Advertisement